These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
645 related items for PubMed ID: 8675144
1. Frequent expression of MUC1 apomucin on biliary epithelial cells of damaged small bile ducts in primary biliary cirrhosis and chronic viral hepatitis: an immunohistochemical study. Sasaki M, Nakanuma Y. Hepatology; 1996 Jun; 23(6):1313-7. PubMed ID: 8675144 [Abstract] [Full Text] [Related]
2. Abnormal expression of MUC1 apomucin and mature MUC1 mucin in biliary epithelial cells in various cystic liver diseases. Sasaki M, Nakanuma Y. Hepatology; 1996 Sep; 24(3):539-43. PubMed ID: 8781320 [Abstract] [Full Text] [Related]
3. Enhanced apoptosis relates to bile duct loss in primary biliary cirrhosis. Harada K, Ozaki S, Gershwin ME, Nakanuma Y. Hepatology; 1997 Dec; 26(6):1399-405. PubMed ID: 9397977 [Abstract] [Full Text] [Related]
4. Increased CD1d expression on small bile duct epithelium and epithelioid granuloma in livers in primary biliary cirrhosis. Tsuneyama K, Yasoshima M, Harada K, Hiramatsu K, Gershwin ME, Nakanuma Y. Hepatology; 1998 Sep; 28(3):620-3. PubMed ID: 9731549 [Abstract] [Full Text] [Related]
5. Increased MUC6 apomucin expression is a characteristic of reactive biliary epithelium in chronic viral hepatitis. Sasaki M, Nakanuma Y, Ho SB, Kim YS. J Pathol; 1998 Jun; 185(2):191-8. PubMed ID: 9713347 [Abstract] [Full Text] [Related]
7. Immunohistochemical analysis of adhesion molecules in the micro-environment of portal tracts in relation to aberrant expression of PDC-E2 and HLA-DR on the bile ducts in primary biliary cirrhosis. Yasoshima M, Nakanuma Y, Tsuneyama K, Van de Water J, Gershwin ME. J Pathol; 1995 Mar; 175(3):319-25. PubMed ID: 7538164 [Abstract] [Full Text] [Related]
9. Hepatitic bile duct injuries in chronic hepatitis C: histopathologic and immunohistochemical studies. Kaji K, Nakanuma Y, Sasaki M, Unoura M, Kobayashi K, Nonomura A, Tsuneyama K, Van de Water J, Gershwin ME. Mod Pathol; 1994 Dec; 7(9):937-45. PubMed ID: 7892163 [Abstract] [Full Text] [Related]
10. Immunohistochemical analysis of cell-matrix adhesion molecules and their ligands in the portal tracts of primary biliary cirrhosis. Yasoshima M, Tsuneyama K, Harada K, Sasaki M, Gershwin ME, Nakanuma Y. J Pathol; 2000 Jan; 190(1):93-9. PubMed ID: 10640998 [Abstract] [Full Text] [Related]
11. Characterization of apomucin expression in intrahepatic cholangiocarcinomas and their precursor lesions: an immunohistochemical study. Sasaki M, Nakanuma Y, Kim YS. Hepatology; 1996 Nov; 24(5):1074-8. PubMed ID: 8903378 [Abstract] [Full Text] [Related]
12. Biliary epithelial expression of MUC1, MUC2, MUC3 and MUC5/6 apomucins during intrahepatic bile duct development and maturation. An immunohistochemical study. Sasaki M, Nakanuma Y, Terada T, Kim YS. Am J Pathol; 1995 Sep; 147(3):574-9. PubMed ID: 7677170 [Abstract] [Full Text] [Related]
13. Activation of ATM signaling pathway is involved in oxidative stress-induced expression of mito-inhibitory p21WAF1/Cip1 in chronic non-suppurative destructive cholangitis in primary biliary cirrhosis: an immunohistochemical study. Sasaki M, Ikeda H, Nakanuma Y. J Autoimmun; 2008 Aug; 31(1):73-8. PubMed ID: 18456456 [Abstract] [Full Text] [Related]
15. Distribution of B lymphocytes in nonsuppurative cholangitis in primary biliary cirrhosis. Nakanuma Y. Hepatology; 1993 Sep; 18(3):570-5. PubMed ID: 8359797 [Abstract] [Full Text] [Related]
16. Are bile duct lesions of primary biliary cirrhosis distinguishable from those of autoimmune hepatitis and chronic viral hepatitis? Interobserver histological agreement on trimmed bile ducts. Zen Y, Harada K, Sasaki M, Tsuneyama K, Matsui K, Haratake J, Sakisaka S, Maeyama S, Yamamoto K, Nakano M, Shimamatsu K, Kage M, Kurose N, Uchiyama A, Kaizaki Y, Toda G, Nakanuma Y. J Gastroenterol; 2005 Feb; 40(2):164-70. PubMed ID: 15770400 [Abstract] [Full Text] [Related]
17. Alterations in tight junctions differ between primary biliary cirrhosis and primary sclerosing cholangitis. Sakisaka S, Kawaguchi T, Taniguchi E, Hanada S, Sasatomi K, Koga H, Harada M, Kimura R, Sata M, Sawada N, Mori M, Todo S, Kurohiji T. Hepatology; 2001 Jun; 33(6):1460-8. PubMed ID: 11391535 [Abstract] [Full Text] [Related]
18. In situ nucleic acid hybridization of cytokines in primary biliary cirrhosis: predominance of the Th1 subset. Harada K, Van de Water J, Leung PS, Coppel RL, Ansari A, Nakanuma Y, Gershwin ME. Hepatology; 1997 Apr; 25(4):791-6. PubMed ID: 9096578 [Abstract] [Full Text] [Related]
19. Peptide antibiotic human beta-defensin-1 and -2 contribute to antimicrobial defense of the intrahepatic biliary tree. Harada K, Ohba K, Ozaki S, Isse K, Hirayama T, Wada A, Nakanuma Y. Hepatology; 2004 Oct; 40(4):925-32. PubMed ID: 15382127 [Abstract] [Full Text] [Related]
20. Abnormal expression of the E2 component of the pyruvate dehydrogenase complex on the luminal surface of biliary epithelium occurs before major histocompatibility complex class II and BB1/B7 expression. Tsuneyama K, Van de Water J, Leung PS, Cha S, Nakanuma Y, Kaplan M, De Lellis R, Coppel R, Ansari A, Gershwin ME. Hepatology; 1995 Apr; 21(4):1031-7. PubMed ID: 7535733 [Abstract] [Full Text] [Related] Page: [Next] [New Search]